Adex (Indapamid)

Quick links to important sections

Adex (Indapamid)

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adex (Indapamid)

Property Description
Active ingredient Indapamide
Form Oral Tablet (Modified-Release)
Pharmacological class Thiazide-like Diuretic, Antihypertensive
Common use Lowering elevated blood pressure (hypertension)
Origin Synthetic (Sulfamyl-Benzamide Derivative)

Adex is a commercial name for a medication whose active ingredient is Indapamide. This drug is a thiazide-like diuretic and a primary antihypertensive agent. Indapamide is a synthetic compound, chemically defined as a sulfamyl-benzamide derivative.

The Definitive Classification and Formulation

Indapamide belongs to the pharmacological group known as thiazide-like diuretics because its mechanism includes acting on the kidneys to promote the removal of excess salt and water. However, its classification also recognizes its unique dual action, which includes a direct effect on blood vessels, providing an advantage over certain older diuretics. This distinctive pharmacological profile is clinically recognized for its efficacy in achieving sustained blood pressure reduction.

Indapamide is presented as an oral tablet, typically manufactured as a modified-release or extended-release formulation. This specific design ensures that the active ingredient is released slowly and consistently over a prolonged duration. Indapamide is a highly effective, once-daily drug for reducing high blood pressure. The general purpose of the medication is to help lower elevated blood pressure by reducing both the total fluid volume in the circulation and the resistance within the blood vessels, making it a foundation of therapy for adult patients with essential hypertension.

What side effects are possible with Adex (Indapamid)?

Possible side effects and safety information

Indapamide's safety profile, as documented in official regulatory sources, is structured around its potential to affect metabolic and cardiovascular systems. The most common adverse reactions listed in prescribing information are typically related to electrolyte disturbance and general discomfort.

Frequency-Classified Adverse Reactions

Classification Examples of Officially Documented Effects
Common Hypokalemia (low potassium levels), Headache, Dizziness, Fatigue, and Maculopapular rash.
Uncommon Vomiting and Orthostatic Hypotension (feeling dizzy upon standing).
Rare Vertigo, Pancreatitis, Hypercalcemia, and Angioedema.
Very Rare Agranulocytosis, Torsade de pointes (a serious heart rhythm abnormality), and Severe skin reactions (SJS/TEN).

Serious Safety Characteristics and Restrictions

Regulatory documents highlight that Indapamide may, rarely, be associated with clinically significant events affecting several System-Organ Classes. These include acute ocular conditions such as Acute Angle-Closure Glaucoma and Acute Myopia, which are noted as having a 'Not Known' frequency. Severe hypersensitivity reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are documented as Very Rare.

Official labels define strict constraints for use, including that the medicine is contraindicated in patients with known hypersensitivity to Indapamide or other sulfonamide derivatives. It is also explicitly restricted in cases of severe hepatic impairment (liver disease) or severe renal impairment (such as Anuria). The safety profile notes that severe electrolyte imbalances, particularly Hyponatremia and Hypokalemia, have been reported more often in older adults, particularly females.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation describes the manifestations of Indapamide overdose primarily as consequences of excessive diuretic activity, leading to severe fluid and electrolyte depletion. All severe symptoms require immediate medical attention.

Documented Overdose Manifestations

Classification Official Regulatory Statement
Common Signs Nausea, vomiting, dizziness, drowsiness, confusion, and generalized weakness.
Cardiovascular Effects Hypotension (low blood pressure) and Tachycardia (rapid heart rate).
Severe Outcomes Profound electrolyte imbalances, specifically Hyponatraemia (low sodium) and Hypokalaemia (low potassium), which can lead to life-threatening cardiac arrhythmias (e.g., Torsade de Pointes).
Specific Risk In patients with hepatic impairment, overdose carries a documented risk of precipitating hepatic encephalopathy and potentially hepatic coma.

Emergency Response Mandate

Urgent medical attention is required immediately if an overdose is suspected or if severe symptoms such as collapse, seizure, or profound confusion are observed. Regulatory labeling mandates that emergency services or a Poison Control Center must be contacted without delay. The management strategy is strictly symptomatic and supportive treatment, as no specific antidote is known for Indapamide. Treatment includes continuous hospital monitoring and the aggressive correction of severe fluid and electrolyte deficits.

Therapeutic Uses of Adex (Indapamid)

Adex (Indapamid) is a medication that is commonly used to help with managing symptoms linked to organ-specific functional stress, particularly those associated with: high blood pressure (hypertension) and edema, which involves symptoms related to fluid retention.

Indapamide may be part of symptomatic management for high blood pressure and may assist with managing symptoms related to fluid retention in situations where patients experience congestion associated with conditions where functional stability becomes affected. It is applied in addressing symptoms related to heightened physiological activity and often used during phases when symptoms become more noticeable. For patients experiencing symptoms that interfere with daily comfort, it provides supportive relief.

The support provided helps ease the overall symptom burden. This application is relevant when supportive symptom management is appropriate for conditions characterized by periods of heightened symptoms. For both conditions, the medication contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.


Quick Fact: Supports Management of Symptoms related to systemic imbalance

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Adex (Indapamid)?

The eligibility profile for Adex (Indapamide) is defined by official regulatory documents, specifying populations where use is forbidden or requires special caution.

Eligibility Status Population/Condition
Contraindicated (Must not use) Hypersensitivity to indapamide or other sulfonamide derivatives.
Anuria (inability to produce urine).
Severe Hepatic Impairment or Hepatic Encephalopathy.
Pre-existing Hypokalaemia (low blood potassium).
Not Recommended/Avoided Children and Adolescents (under 18 years) due to lack of established safety and efficacy data.
Breastfeeding women (due to unknown excretion into breast milk).

Eligibility-related restrictions apply to several populations. Patients with severe renal impairment are generally contraindicated, while patients with less severe kidney or liver disease must use the medication with caution and require regular monitoring. Caution is also advised for older adults, and those with a history of gout or diabetes mellitus, as use may exacerbate these conditions. In pregnancy, routine use of diuretics is generally avoided unless necessary for pathological causes. The primary eligible group consists of adults aged 18 and over who do not have any of the listed contraindications or severe pre-existing conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Indapamide primarily around its effects on electrolyte balance and blood pressure. These interactions often stem from either additive pharmacodynamic effects or altered clearance of co-administered substances.

Interaction Classifications

Formal Prohibitions and Restrictions

Substance Constraint/Outcome as Stated in Label
Aliskiren Co-administration is formally contraindicated in patients with diabetes mellitus.
Lithium Co-administration is generally not recommended due to reduced renal clearance, increasing the risk of Lithium toxicity.
Simvastatin Dose is restricted and must not exceed 20 mg daily when co-administered.

Documented Pharmacodynamic Effects

Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce the antihypertensive effect of Indapamide and increase the risk of renal impairment. Similarly, combining with other hypokalemia-inducing agents (e.g., Corticosteroids) or QTc-prolonging drugs increases the documented risk of severe electrolyte imbalance or cardiotoxicity. Alcohol may potentiate the risk of orthostatic hypotension.

Administration Requirements

Specific administration constraints exist, such as the instruction to withhold Indapamide for 24 hours prior to administration of high-dose Amifostine. Population-specific notes indicate that the risk of electrolyte-related complications is heightened in cases of severe hepatic impairment.

Mechanism of Action

Adex (Indapamid) functions primarily as a thiazide-like inhibitor targeting the Na^+/ Cl^- cotransporter (NCC), also known as solute carrier family 12 member 3 ( SLC12 A3). This protein is selectively located in the apical membrane of epithelial cells within the distal convoluted tubule of the nephron. By binding to and inhibiting NCC, indapamide prevents the coupled reabsorption of sodium ( Na^+) and chloride ( Cl^-) ions from the tubular lumen back into the systemic circulation. This inhibition increases the concentration of Na^+ and Cl^- within the tubule, leading to an osmotic downstream cascade that retains water in the lumen. The resulting greater volume of fluid is subsequently eliminated, producing a systemic physiological consequence of volume reduction. Indapamide also possesses a secondary mechanism due to its lipophilicity, accumulating in vascular smooth muscle cells. Within these cells, it modulates calcium channels, leading to a decrease in intracellular free Ca^2+ concentration, which is associated with a reduction in peripheral vascular resistance.

Dosage and Administration Information

How to Use Adex (Indapamid)

The usage of Indapamide follows a fixed daily regimen using the oral tablet form. The specific instructions ensure the medication maintains its desired therapeutic release profile over a full 24-hour period, which is essential for its intended long-term use in chronic management.


Official Administration Guidelines

Instruction Detail
Route of Administration Oral administration only.
Standard Dosing Modified-Release (MR): 1.5 mg once daily. Immediate-Release (IR): 1.25 mg once daily, which may be adjusted up to 2.5 mg once daily.
Frequency and Timing The medicine is taken once daily, typically instructed for administration in the morning.
Intake Condition The tablet may be taken with or without food.
Duration of Use Treatment is generally for long-term maintenance of chronic conditions.

Procedural Instructions and Constraints

Administration of the Indapamide tablet is procedural and non-flexible, particularly concerning the modified-release formulation:

  • The tablet must be swallowed whole with water. It is emphasized that the MR tablet must not be crushed, chewed, or divided to preserve the controlled release of the active ingredient.
  • If a dose is missed, patients are instructed to skip the missed dose and take the next dose at the regularly scheduled time the following day. It is stated that doubling the dose is not permitted.
  • Official labeling specifies constraints regarding severe organ dysfunction, indicating that use is typically not recommended in patients with severe renal or hepatic impairment.

These instructions define the standardized approach for continuous use of Indapamide.

Recent Clinical Evidence

Indapamid, a thiazide-like diuretic marketed as Adex, has been extensively studied in large, international clinical trials for the management of hypertension. Recent evidence underscores its role in blood pressure control and long-term cardiovascular protection.

Efficacy in Blood Pressure Reduction

Clinical trials have consistently shown that Indapamid, particularly in its sustained-release (SR) formulation, contributes to a significant and sustained reduction in blood pressure. Findings from key meta-analyses indicate that the drug effectively lowers both systolic blood pressure (SBP) and diastolic blood pressure (DBP) over a 24-hour period. Studies have also reported that SBP reductions may be greater than those achieved with some other classes of antihypertensive agents, especially in patients with isolated systolic hypertension (ISH).

Primary Efficacy Finding Study Focus
Significant reduction in SBP and DBP Mild to moderate essential hypertension
Sustained 24-hour blood pressure control Comparison of sustained-release formulation (SR)
Reduction in Left Ventricular Mass Index Assessment of target-organ protection

Impact on Cardiovascular Outcomes

Beyond simply lowering blood pressure, a significant focus of recent research is the effect of Indapamid-based therapy on major cardiovascular events. Large randomized trials have explored its benefits, often in combination with other agents like Perindopril (an ACE inhibitor).

  • Stroke Prevention: Studies have indicated that treatment regimens including Indapamid are associated with a reduction in the risk of stroke, particularly in patients with a history of stroke or in elderly patients with hypertension.
  • Vascular Death: Combination therapy involving Indapamid has been associated with a significant reduction in the risk of vascular death and major cardiovascular events in patients with a high cardiovascular risk profile.

Metabolic and Safety Profile

Indapamid is generally well tolerated, with its safety profile often compared favorably to traditional thiazide diuretics. Clinical trials have investigated its potential metabolic effects:

  • Electrolytes: The drug can be associated with dose-related reductions in serum potassium (hypokalemia), which is a common effect of diuretics.
  • Metabolic Markers: Research shows that, unlike some other diuretics, Indapamid maintains a neutral effect on the high-density/low-density lipoprotein-cholesterol balance, which is important for overall cardiovascular health.

Key Studies & References

  1. Combination of perindopril/indapamide in secondary prevention of stroke and other vascular events: A combined analysis of ADVANCE, PROGRESS and HYVET trials
  2. Indapamide: the diuretic of choice for managing blood pressure in Indian populations
  3. Indapamide Tablets, USP Full Prescribing Information (FDA Label)

Frequently Asked Questions (FAQ)

Common questions about Adex (Indapamid) (FAQ)


Q: Is it necessary to avoid alcohol completely while on Indapamid?

Regulatory documents note that consumption of alcohol may potentiate the risk of orthostatic hypotension, which is a drop in blood pressure when standing up that can cause dizziness. Because of this risk, official information indicates that alcohol consumption should be approached with caution.


Q: What is the difference between Indapamid and other diuretics like Hydrochlorothiazide?

Indapamide is characterized as a 'thiazide-like' diuretic. According to official product information, it has a dual mechanism of action, which includes a direct effect on the blood vessels to reduce resistance, in addition to its function of promoting fluid elimination.


Q: Can Indapamid cause muscle cramps or weakness?

Yes, muscle cramps and muscle weakness are officially documented adverse reactions associated with this medication. They are noted as possible warning signs of a serious change in the body’s electrolyte balance, such as low potassium.


Q: What kind of medical monitoring is typically needed while taking Adex?

Regular medical monitoring is necessary to track the body’s response to the drug. Monitoring typically involves checks of blood pressure, electrolyte levels (like potassium and sodium), and kidney and liver function while taking this medication.


Q: Does taking Adex affect my blood sugar levels?

Official guidance suggests that the drug may maintain a neutral metabolic profile, though monitoring of blood glucose is advised, especially in patients with diabetes or if a low potassium level occurs.


Q: Can men and women expect different side effects from Adex?

Regulatory documents note that severe electrolyte imbalances, specifically low sodium (hyponatremia) accompanied by low potassium (hypokalemia), have been reported more often in older adult females.


Q: Is Adex a common prescription for elderly patients?

While regulatory sources do not quantify how common the prescription is, they specify that special caution and more frequent monitoring, especially for electrolytes, are advised when the medication is prescribed to older adults.


Q: Does Indapamid interact with supplements like magnesium or calcium?

Thiazide-related diuretics may cause a slight rise in plasma calcium levels. Taking large amounts of calcium, such as supplements, is associated with an increased risk of a serious condition called milk-alkali syndrome.


Q: Are there any food restrictions I should be aware of while taking Indapamid?

The tablet may be taken with or without food. However, treatment for high blood pressure often requires changes in diet, such as following a low-sodium or low-salt diet, and in some cases, incorporating potassium-rich foods, as advised by a healthcare provider.


Q: Does Adex help with swelling (edema) or is it just for blood pressure?

Official regulatory documents indicate that Indapamide is also used to address salt and fluid retention, known as edema, caused by conditions such as congestive heart failure, in addition to its primary use in treating high blood pressure.


Q: Does Adex affect hormones or have any other long-term body changes?

The drug may cause a slight and temporary rise in plasma calcium levels. Official information indicates the medication is associated with a neutral effect on long-term lipid and glucose metabolism; effects on other specific hormones are not generally documented in regulatory summaries.


Q: What is the general patient experience reported with Indapamid?

Official reports on adverse reactions indicate that side effects are generally mild and temporary. The most frequently reported effects include fatigue, headache, dizziness, and muscle cramps (potential signs of low electrolytes), usually occurring within the first month of treatment.


Q: Does Indapamid always cause me to go to the bathroom more often?

As a diuretic, Indapamide works by increasing the flow of urine to reduce fluid in the body. While you may notice increased urination when first starting the medication, this effect may become less noticeable over time.


Q: How quickly does Adex start working to lower blood pressure?

The drug is quickly absorbed, with peak levels in the blood typically reached within one to two hours of taking the tablet. However, official information indicates that the full therapeutic effect on blood pressure may not be reached until several months of consistent daily use.


Q: Does taking Adex mean I need to watch my salt intake?

Treatment for high blood pressure is often managed with lifestyle adjustments, including minimizing foods high in sodium (salt). A doctor is the source to advise you on whether a specific low-sodium diet is a necessary part of your treatment plan.


Q: Can Indapamid cause dry mouth or thirst?

Yes, dry mouth and increased thirst are documented signs of a potential electrolyte imbalance. Official product information notes that patients should be monitored for these symptoms while taking the drug.


Q: Can taking Adex make me sensitive to the sun?

Cases of photosensitivity reactions have been reported with thiazides and similar diuretics, including Indapamide. Regulatory sources suggest that if a photosensitivity reaction occurs, discontinuation of the treatment is recommended.


Q: What should I do if I think I'm experiencing a mild side effect from Indapamid?

Official guidelines indicate that any symptoms of adverse effects should be reported to a healthcare professional. This is especially important for signs of electrolyte imbalance, such as persistent weakness, dizziness, or muscle cramps.


Q: Is the brand name Adex used in all countries?

No. While the active ingredient is always Indapamide, the medication is marketed under many different brand names globally. Examples of other brand names include Natrilix, Indipam, or Rawel.


How should Adex (Indapamid) be stored and disposed of?

Official Storage and Disposal Guidelines for Adex (Indapamide)

These storage and disposal requirements are based on official government regulatory documents.

Storage Requirements

Adex must be stored in its original, closed container at room temperature. Protection from certain environmental conditions is essential for maintaining product stability and integrity.

Condition Type Official Requirement
Temperature Store at room temperature; keep from freezing.
Protection Store away from heat, moisture, and direct light.
Safety Keep out of the reach of children.

Disposal Instructions

To ensure safety, do not keep outdated medicine or medicine no longer needed. The product should not be disposed of in household trash or flushed down a toilet. Patients are instructed to ask a healthcare professional how they should dispose of any medicine they do not use to comply with proper local procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adex (Indapamid) found in:

A-Z Index: